News
ACA insurers propose 14% premium hike for 2027
11+ hour, 14+ min ago (383+ words) Median rate filing shows double-digit growth after enhanced subsidies lapsed at year-end 2025. ACA Marketplace insurers are proposing a median premium increase of 14% for 2027, marking a likely second consecutive year of double-digit increases that would push typical premiums up more than…...
Medicare Advantage prior authorization problems
12+ hour, 26+ min ago (154+ words) Minority and dual-eligible patients face stricter coverage rules, study shows. This paid access article from Health Affairs discusses prior authorization in the Medicare Advantage program. Specifically, the authors found that these plans with high prior authorization rates are driving patients…...
Scaling your Field Reimbursement Program with Confidence webinar
1+ day, 9+ hour ago (117+ words) Bio Xconomy Scaling Your Field Reimbursement Program with Confidence: What maturity looks like & why it matters Built for the access challenges mature Field Reimbursement programs are increasingly asked to solve. Today's access environment demands more than reactive case handling. As…...
OIG finds Medicare drug pricing payment issues
1+ mon, 1+ week ago (341+ words) Agency finds vertical integration raises enrollee out of pocket costs while premiums stay low. The Office of Inspector General (OIG) plays a critical role in combating fraud, waste, and abuse across Department of Health and Human Services (HHS) programs, while…...
Center Well and Cost Plus Drugs cut drug costs
2+ mon, 3+ day ago (409+ words) Center Well Pharmacy, a specialty and home delivery pharmacy division of Humana Inc. , recently announced a new partnership with Mark Cuban Cost Plus Drug Company to create a new prescription drug delivery model aimed at lowering costs and improving medication…...
Bristol Myers Squibb tackles Medicare pricing rules
3+ mon, 6+ hour ago (212+ words) BMS shares insights on adapting to Medicare pricing rules, highlighting teamwork and strategic planning. Tim Kocses, executive director, US commercial controller at Bristol Myers Squibb (BMS) took the stage at Life Sciences Accounting and Reporting Congress to discuss the company's…...